Gabriela Pittis discusses the Argentinian healthcare system's ability to diagnose, treat, and regulate rare diseases, and the country’s progress in…

The Chairman and CSO of TCM Biotech offer perspectives on the potential of botanical drugs, and chart their biotech company's trajectory in bringing…

As the only country in the G8 without an orphan drugs act, the president of Médunik, a company focused on bringing orphan drugs into the country,…

Could you begin by giving a short introduction to Nordic Drugs and its current position within the structure of owner Nordic Group? Nordic Drugs…

Mr. Mazeman, can you please begin by offering a brief overview of your career to date? I am a French pharmacist by training, with expertise in…

Since the company’s foundation in 1993, Hetero has clearly come a long way. What were the key success factors at that time, which laid the…